Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

Purpose: This study examined the effect of frequent nutritional counseling on oral intake, body weight, response rate, survival, and quality of life in patients with cancer of the lung (small-cell), ovary, or breast undergoing cyclic chemotherapy.

Patients And Methods: Of 105 assessable patients, 57 were randomized to receive nutritional counseling, and 48 to receive no nutritional counseling and consumption of an ad lib oral intake. The intervention group was counseled to achieve a daily energy and protein intake according to recommended dietary allowances.

[Food intake, depressed appetite and chemosensory threshold in patients with cancer during chemotherapy].

Energy and protein intake and eating-related complaints were studied in 52 patients with cancer of the breast, ovary or lung prior to and after 1 and 3 cycles of chemotherapy. Pretreatment intakes were somewhat lower than recommended, but did not change after therapy. Many patients had eating-related complaints, but these complaints did not increase after therapy.

Dietary intake in patients with small cell lung cancer: the effect of aggressive chemotherapy.

Energy and protein intake in 32 consecutive patients with small cell lung cancer was examined at initiation of cyclical chemotherapy and after 1 and 3 months. With each cycle intakes decreased in the first 2 days following chemotherapy, but were back to pretreatment levels on the third day. Eleven of the patients lost weight in the study period.

Tumour regression following chemotherapy does not increase food intake.

Forty-six patients with cancer of the breast, ovary or lung (small cell) were followed for 5 months after initiation of cyclical chemotherapy to examine if any changes in voluntary food intake or nutritional status were related to treatment response. The study showed a slight decrease in protein (P less than 0.05) and energy intake (not significant) at 3 months compared to pretreatment intakes in 31 patients with objective tumour regression.

Different quantities of two commercial liquid diets consumed by weight-losing cancer patients.

Twenty ambulatory, weight-losing patients with advanced cancer of the lung, breast, or ovary were randomized to supplement their diet for 2 months with either of two commercial complete liquid diets, one containing intact milk proteins and the other partially hydrolyzed soy proteins. Both products were prescribed as sip feeds in addition to normal food. The patients consumed more of the hydrolysate-containing product than of that with intact (milk) protein.